15.02.2014 20:21:21
|
Biogen Idec Chairman William Young To Retire - Quick Facts
(RTTNews) - Biogen Idec (BIIB) Saturday announced that Chairman of the Board William (Bill) Young will retire from the company's Board, effective at the 2014 annual meeting of stockholders. Young has been a member of Biogen Idec's Board since 1997 and has served as Chairman since 2010.
Stelios Papadopoulos, a member of Biogen Idec's Board since 2008, has been appointed to assume the role of Chairman following the end of Young's term.
Papadopoulos is the former Vice Chairman of Cowen & Co. LLC and is the current Chairman of the Board at Exelixis Inc., a drug discovery company that he cofounded in 1994, and at Regulus Therapeutics Inc. Papadopoulos is also currently a member of the Board of Directors of BG Medicine Inc.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Biogen Incmehr Nachrichten
24.02.25 |
NASDAQ Composite Index-Titel Biogen-Aktie: So viel hätte eine Investition in Biogen von vor 10 Jahren gekostet (finanzen.at) | |
17.02.25 |
NASDAQ Composite Index-Titel Biogen-Aktie: So viel hätten Anleger an einem Biogen-Investment von vor 5 Jahren verloren (finanzen.at) | |
13.02.25 |
Gewinne in New York: NASDAQ 100 legt zum Start des Donnerstagshandels zu (finanzen.at) | |
12.02.25 |
Angespannte Stimmung in New York: S&P 500 zum Handelsende schwächer (finanzen.at) | |
12.02.25 |
NASDAQ 100 aktuell: NASDAQ 100 liegt schlussendlich im Plus (finanzen.at) | |
12.02.25 |
Angespannte Stimmung in New York: S&P 500 am Mittwochnachmittag im Minus (finanzen.at) | |
12.02.25 |
Freundlicher Handel: NASDAQ 100-Anleger greifen zu (finanzen.at) | |
12.02.25 |
Börse New York: Das macht der NASDAQ Composite nachmittags (finanzen.at) |
Analysen zu Biogen Incmehr Analysen
Aktien in diesem Artikel
Biogen Inc | 134,05 | -0,11% |
|